Replimune Group, Inc – a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies – has announced that the US Food and Drug Administration (FDA) has issued a ...
Illustration of main trading floor and digital index display screen at the Indonesia Stock Exchange (IDX) building in Jakarta. Tempo/Tony Hartawan TEMPO.CO, Jakarta - The Indonesia Stock Exchange (IDX ...
Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The ...
Good news strikes from an unlikely source. On Thursday the Food and Drug Administration approved Replimune’s immunotherapy for metastatic melanoma, a day after it green-lighted mFlusiva, Moderna’s ...
Aug 6 (Reuters) - The U.S. Food and Drug Administration has approved Replimune's (REPL.O), opens new tab drug for a difficult-to-treat form of skin cancer, the company said on Thursday, giving the ...
In a remarkable turnaround, Replimune has reversed the fortune of its melanoma therapy, winning FDA approval after two prior rejections and agency leadership shakeups. Thursday, the FDA granted ...
Rega makes excellent hi-fi gear. Its turntables are the stuff of legend, its amplifiers have excelled for decades, and I have never heard anyone in the industry speak ill of Roy Gandy, the company’s ...
After FDA approval of RP1 plus nivolumab, melanoma specialists now look toward preparing for clinical use and consider the future of intratumoral therapy trials. The decision followed the July 30, ...
Kevin Harrington, Professor in Biological Cancer Therapies at Institute of Cancer Research, shared on LinkedIn: “In addition to my earlier re-posting of the FDA announcement of the approval of ...
Three submissions, two rejections, one public fight with the FDA, and, finally, an approval. On August 6, 2026, the U.S. Food and Drug Administration granted accelerated approval to Tudriqev ...
As of August 5 at 12:00:00 AM UTC. Market Open. Loading chart for ^CLCTBLS.REGA ...
Replimune can finally feel a sense of vindication. After two rejections, public clashing with the previous FDA leaders and a closed-door meeting with the White House, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results